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ABSTRACT
Background: Cough variant asthma has recently been described, mainly as airway inflammation in relation to
bronchial asthma, but the relationship between the two types of asthma remains unclear. Further studies of
cough receptor sensitivity are necessary to fully characterize cough variant asthma.
Methods:We assessed the relevance of testing cough sensitivity using an Astograph with continuous cap-
saicin inhalation, and compared the results with those obtained using intermittent inhalation. We showed the
clinical applicability of testing cough sensitivity (0.15680µM capsaicin; five or more coughs, 1 minute of con-
tinuous inhalation at each concentration) using this method. We compared cough sensitivity among patients
with pure cough variant asthma who did not develop bronchial asthma after an observation period of at least 1
year, patients with bronchial asthma and healthy individuals.
Results: The continuous cough sensitivity test using the Astograph was reproducible and reliable. Cough
sensitivity in patients with pure cough variant asthma was significantly higher than that in healthy individuals.
Conclusions: The cough sensitivity of patients with cough variant asthma is not necessarily identical to that of
healthy individuals.
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INTRODUCTION
Cough variant asthma (CVA) is a condition charac-
terized by a chronic dry cough. It has recently been
described mostly as airway inflammation in relation
to bronchial asthma,1,2 but the relationship between
the two types of asthma remains obscure. Two cough
mechanisms have been considered for CVA: (1) very
mild airway constriction unaccompanied by a reduc-
tion in pulmonary function or wheezing, and (2) in-
creased cough receptor sensitivity.3-5 Whereas bron-
choconstriction is measured by the airway respon-
siveness test, the degree of cough receptor sensitivity
has not been fully studied to characterize CVA.
Coughing usually results from stimulating sensory
nerves in the airway.6 Irritant receptors and possibly
C-fiber endings are generally recognized as airway
cough receptors.7 Capsaicin is the active ingredient
of red pepper and it is thought to induce coughing
mainly by stimulating C-fiber endings,8 although its
action may be indirect.7 Moreover, O’Connell et al.9
have investigated the potential role of central cholin-
ergic and dopaminergic receptors in cough mediation
by capsaicin, and the potential role of 5-HT receptors
in the antitussive action of opiates.
The cough sensitivity test often includes capsaicin.
However, the method varies in terms of concentra-
tion and the duration of inhalation,10-12 and has not
been standardized. Before investigating patients with
cough variant asthma, we assessed the usefulness of
the Astograph during continuous capsaicin inhala-
tion without intervals . 13 We tested cough receptor
sensitivity and compared CVA without asthmatic
symptoms (pure CVA) with typical bronchial asthma
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Fig. 1 Cough sensitivity test using intermitent and continuous methods. Two-fold serial dilutions of capsaicin (0.156
―80 μM) were sequentialy inhaled using both methods, from the lowest concentration for 1 minute, until five or 10 
coughs were induced.
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Table 1 Characteristics of subgroups.
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METHODS
COUGH SENSITIVITY TEST
The Astograph (TCK-6000M, Chest Corp, Tokyo,
Japan) assesses bronchial responsiveness to meth-
acholine, and it has been widely applied in Japanese
clinical practice.13 If the Astograph can be used to
evaluate cough sensitivity, it will help to promote test-
ing of this parameter. We examined the usefulness of
the method involving the Astograph and continuous
capsaicin inhalation without intervals , as described
below. We firstly compared an intermittent method
with a 2-minute observation period after inhalation
and a continuous method without an observation pe-
riod to determine the need for observation while in-
creasing the inhaled concentration. The participants
comprised 20 healthy non-smokers ( 11 men ; 9
women; mean age, 26.5 ± 2.0 years) without a medical
history of respiratory diseases such as bronchial
asthma or pulmonary emphysema. None of the par-
ticipants had a respiratory infectious disease within 2
months of the study, which proceeded in accordance
with the guiding principles for human experimenta-
tion summarized in the most recent version of the
Helsinki Declaration.
Capsaicin (Sigma Chemical, Poole, U.K.) was dis-
solved in ethanol at a concentration of 1 × 10−2 moll,
and 1 ml was added to 9 ml of physiological saline.
Thereafter , 2  3 drops of polyoxyethylenesorbitan
monooleate 80 (Tween 80) was added to bring the fi-
nal concentration of capsaicin to 1 × 10−3 moll. This
solution was further diluted to 80µM and then serially
diluted to 40, 20, 10, 5, 2.5, 1.25, 0.625, 0.313 and
0.156µM. Cough sensitivity was assessed using the
Astograph. Participants inhaled sequential capsaicin
dilutions for 1 minute, starting with the lowest con-
centration, until five or 10 coughs were induced, to
establish the cough sensitivity threshold. As an evalu-
ation parameter, the concentration at which the total
number of coughs per minute was 10 or more was
designated as C10min, and its logarithm was desig-
nated as LogC10min. Similar parameters were ap-
plied using five or more coughs as the index (C5min
and LogC5min). We then compared the intermittent
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Fig. 2 Efects of intermitent or continuous inhalation on cough threshold to inhaled cap-
saicin in normal individuals.(a) Log capsaicin concentration required to elicit five coughs 
(C5min). (b)Log C5min or C10min did not difer between the two methods.
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method with a 2-minute observation period after in-
haling capsaicin at each concentration and the con-
tinuous inhalation method without observation
(Fig. 1).
COUGH SENSITIVITY IN PATIENTS WITH CVA
We investigated the cough threshold in 29 non-
smoking patients (12 men; 17 women; mean age, 50.9
± 3.1 years) with CVA using the continuous capsaicin-
inhalation cough sensitivity test (Table 1) at the De-
partment of Respiratory Medicine of Kobe University
Hospital. Patients with typical asthma for over 1 year
were excluded. Patients with subjective paroxysmal
dyspnea and wheezing during the first examination,
wheezing detected by auscultation, underlying respi-
ratory disease, chronic bronchitis, respiratory infec-
tious diseases within 8 weeks of the first examination
and those medicated with ACE inhibitors were also
excluded. Twenty-two patients (7 men; 15 women;
mean age, 49.7 ± 4.1 years) with bronchial asthma
had symptoms typical of wheezing and dyspnea (Ta-
ble 1). In addition to measurements of cough sensitiv-
ity, the patients underwent a detailed inquiry as well
as evaluations of pulmonary function and airway hy-
persensitivity to inhaled methacholine. Each partici-
pant provided written informed consent to all proce-
dures associated with the study.
The diagnosis of CVA at the first examination was
based on the following findings based on the report
of Corrao et al. 6: typical episodes of wheezing and
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Fig. 3 Number of coughs induced during four consecutive 15-second periods of capsaicin inhala-
tion for 1 minute. (a) Capsaicin inhalation to induce 10 coughs. (b) Capsaicin inhalation required to 
induce five coughs. Two assessments found no significant diferences among any 15-second peri-
ods (* p＜0.05).
Number of cough Number of cough
10
8
6
4
2
0
0―15 15―30 30―45 45―60
Time (sec)
Intermittent
breathing
Continuative
breathing
＊P＜0.05
＊
＊
10
8
6
4
2
0
0―15 15―30 30―45 45―60
Time (sec)
＊
＊
＊
＊
(a)
10
8
6
4
2
0
10
8
6
4
2
0
0―15 15―30 30―45 45―60
Time (sec.)
0―15 15―30 30―45 45―60
Time (sec.)
＊P＜0.05
＊
＊
Number of cough Number of cough
Intermittent
breathing
Continuative
breathing
(b)
wheezing in auscultation were absent, airway hyper-
responsiveness was confirmed by methacholine inha-
lation, coughing was reduced or resolved by bron-
chodilators such as oral theophylline or clenbuterol
and inhaled β2-agonists and CVA did not develop into
classical asthma accompanied by wheezing and dysp-
nea during the observation period.
Cough sensitivity was measured using the Asto-
graph. Two-fold serial dilutions of capsaicin (0.156
80µM) were sequentially inhaled for 1 minute without
intervals. The concentration required to induce five
coughs and its logarithm were designated as C5min
and LogC5min, respectively.
PULMONARY FUNCTION TEST
Forced expiratory volume in 1 second, and the ratio
(%) of the forced expiratory volume in 1 second were
measured using a spirometer (Autospirometer
System-55; Minato Medical Science Co., Ltd., Osaka,
Japan) during the first examination.
MEASUREMENT OF AIRWAY RESPONSIVE-
NESS
The methacholine inhalation test proceeded as de-
scribed by Takishima et al.13 using the Astograph .
This instrument can generate dose-response curves
of respiratory resistance with tidal breathing during
continuous methacholine (two-fold incremental con-
centrations from 0.049 to 25 mgmlmin) inhalation.
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Fig. 4 Reproducibility of induction of at least five coughs by 80 μM capsaicin. Thresholds deter-
mined in the first and second tests did not significantly difer (corelation coeficient, R＝0.78).
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The following index addressed the pathogenesis of
bronchial hyperresponsiveness : cumulative dose of
methacholine when respiratory conductance (Grs )
was decreased by 35% from the baseline (PD35Grs).
All participants were studied between 1 and 3 p.m.
Bronchodilators , xanthine derivatives and steroids
were not administered for 24 hours before the exami-
nation.
STATISTICAL ANALYSIS
All data are expressed as means ± standard deviation
(SD). The C5min and PD35Grs values were statisti-
cally analyzed on logarithmically transformed data us-
ing the Mann-Whitney U test. Logistic regression was
analyzed using StatView J-5.0 (Hulinks Inc. Tokyo, Ja-
pan). A p value of <0.05 was taken to indicate a signifi-
cant difference.
RESULTS
COUGH SENSITIVITY TEST
Figure 2 shows the cough thresholds required to in-
duce five or more coughs and compares the intermit-
tent and continuous methods. The LogC5min and
LogC10min values did not significantly differ between
the intermittent and continuous methods (R = 0.795
p<0.01 and R = 0.74, respectively; (Fig. 2a, b). How-
ever , in the test investigating the threshold for 10
coughs, 10 or more coughs could not be induced
even at the highest capsaicin concentration (80 µM)
in two of 20 patients.
The 1-minute inhalation was divided into 15-second
periods, and the frequency of coughing at the cough
threshold concentration was determined for each pa-
tient (Fig. 3a,b). The frequency was not significantly
biased in either method.
The reproducibility of the test inducing five or
more coughs was investigated. A comparison of the
cough thresholds obtained in the first and second
tests revealed no significant differences and a good
correlation (Fig. 4).
COUGH SENSITIVITY THRESHOLD IN PATIENTS
WITH COUGH VARIANT ASTHMA
Methacholine-induced airway hyperresponsiveness
in pure CVA and typical asthma did not significantly
differ (Fig. 5).
The C5min value was significantly lower in patients
with pure CVA than in healthy individuals (5.8 ± 2.8
vs. 6.4±1.9 µM, respectively, p <0.05), indicating that
cough sensitivity was increased in the former com-
pared with the latter. However, the value did not sig-
nificantly differ between pure CVA and typical asthma
(Fig. 6).
DISCUSSION
Capsaicin has been widely applied to clinically assess
cough sensitivity. Some investigators10-12 have used
the intermittent method with an observation period of
about 45 or 60 seconds after inhaling various
amounts of capsaicin . Although a standard cough
sensitivity test has been established, the applicability
of continuous inhalation without intervals to the de-
termination of cough threshold has not yet been de-
fined as an alternative method . In our continuous
method, various concentrations of capsaicin were set
in the Astograph using a similar protocol to the
methacholine challenge test with the following pre-
dicted benefits: simple, rapid protocol with a constant
maneuver that is straightforward for the participants.
To determine the appropriate duration of capsaicin
inhalation , 60 seconds were divided into four 15-
second periods, and the frequency of coughing was
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Cough Sensitivity in Pure Cough Variant Asthma
Fig. 5 Bronchial responsiveness to inhaled meth-
acholine in patients with typical asthma and pure 
CVA. Log PD35Grs did not significantly difer be-
tween typical asthma and pure CVA.
Log PD35Grs
(units)
2.0
1.4
0.8
－0.4
－1.0
Typical asthma Pure CVA
NS
0.2
Fig. 6 Cough threshold for capsaicin in patients with typi-
cal asthma, pure CVA and normal individuals. Cough thresh-
old (C5min) of patients with pure CVA was significantly 
lower than that of normal individuals (5.8 ± 2.8 vs. 6.4 ± 1.9
 μM; p＜0.05). Log C5min between patients with pure CVA 
and with typical asthma did not significantly difer.
P＜0.05
Log C5min
(units)
Typical
asthma
Pure
CVA
Normal
2.0
1.0
0
－1.0
determined. Midgren et al. reported that when rela-
tively high concentrations of capsaicin ( 10 and
50 µM) that induce at least 10 coughs are inhaled,
most coughs occurred within the first 30 seconds and
particularly within the first 15 seconds. 11 They de-
scribed this as being due to partial tachyphylaxis to
repeated capsaicin inhalation. Although they also ex-
amined concentrations above the threshold, we inves-
tigated the cough threshold for over 60 seconds, dur-
ing which none of the participants developed tachy-
phylaxis to capsaicin. We propose that inhalation for
60 seconds is necessary because the first 15 seconds
is not sufficient to gradually increase the concentra-
tion from below the cough threshold for each individ-
ual. In addition, the cough threshold was not signifi-
cantly different between the intermittent and continu-
ous methods, suggesting that an interval is not neces-
sary for executing the cough sensitivity test.
We compared cough thresholds between patients
with CVA and healthy controls using continuous cap-
saicin inhalation. As Corrao et al. reported , 14 CVA
might be a mild form or a prodrome of bronchial
asthma. Although CVA was detected during the first
examination, it often clinically developed into bron-
chial asthma over time. We found that 35% of CVA pa-
tients eventually develop asthmatic symptoms of
wheezing and dyspnea . 15 Others 16 have suggested
that to obtain accurate test findings of pure CVA, a
specific observation period might be required and pa-
tients who transit to typical bronchial asthma should
be excluded. The patients diagnosed with CVA at the
beginning of the study were actually at a very early
stage of bronchial asthma, and thus it is unlikely that
these patients actually have pure CVA.
Fujimura et al.17 recently defined atopic coughing
as a chronic dry cough, a predisposition to atopy, a
negative bronchodilator effect and eosinophilic in-
flammation in relatively central airways. Their study
found that cough receptor sensitivity was increased
in atopic cough, but normal in CVA and in bronchial
asthma. Although we concur that the mechanisms of
airway hyperresponsiveness and cough receptor sen-
sitivity differ , we question whether the levels of
cough receptor sensitivity in patients with CVA and
bronchial asthma are similar to those of healthy indi-
viduals. Cough sensitivity considerably varies when
patients with CVA and bronchial asthma are included
in one group, but treatment improves coughing as
well as cough sensitivity.16 However, airway hyperre-
sponsiveness and cough sensitivity arise through dif-
ferent mechanisms. Therefore, several causative fac-
tors of chronic dry cough, CVA and bronchial asthma
in particular , would be present other than atopic
cough with increased cough sensitivity.
Thus, we established an observation period of at
least 1 year to differentiate relatively pure CVA, ex-
cluded patients who transited to bronchial asthma,
and defined the remaining patients with CVA as hav-
ing “pure” CVA. We then compared the cough sensi-
tivity of this group with that of healthy individuals. As
noted,18 the cough threshold between healthy indi-
viduals and patients with bronchial asthma did not
significantly differ. However , our data showed that
the threshold was significantly lower in patients with
pure CVA than in healthy individuals. The results of
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this study suggested that the cough sensitivity of pa-
tients with CVA is not necessarily equal to that of
healthy individuals . Some patients who transit to
bronchial asthma or who have very early stage bron-
chial asthma may have been included in the CVA
group even after the 1 year observation period .
Therefore, a sufficiently long observation period must
be established to exclude these patients from the
study.
In conclusion, we applied continuous capsaicin in-
halation and used an Astograph to show the clinical
usefulness of the cough sensitivity test. In addition,
the cough sensitivity of patients with pure CVA that
did not develop into bronchial asthma after at least 1
year was significantly higher than that in healthy indi-
viduals. Obtaining cough sensitivity information from
patients with CVA and with bronchial asthma should
help to characterize CVA, and observation for several
years might be necessary to accumulate sufficient
data
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